Contineum Therapeutics Insider Trades
NASDAQ: CTNMHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 31 · $1.86M
- Shares bought / sold
- 0 / 122.70K
- Net activity
- Net selling $1.9 million
Contineum Therapeutics insider activity
Over the last 12 months, Contineum Therapeutics insiders reported 51 transactions on SEC Form 4: 0 open-market purchases and 31 sales. Insiders bought $0 and sold $1.9 million worth of stock, for net insider selling of $1.9 million. The largest seller was Lorrain Daniel S., with $1.1 million in reported sales.
The most recent filing shows Stengone Carmine N. (CEO and President) reporting a transaction in 2,500 shares at $1.01 on Sep 8, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put CTNM's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
CTNM insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 8, 2026 | Stengone Carmine N.CEO and President | Sale | 2,500 | $41.14K | Form 4 |
| Sep 8, 2026 | Stengone Carmine N.CEO and President | Option exercise | 2,500 | $2.52K | Form 4 |
| Aug 3, 2026 | Stengone Carmine N.CEO and President | Sale | 2,500 | $40.03K | Form 4 |
| Aug 3, 2026 | Stengone Carmine N.CEO and President | Option exercise | 2,500 | $2.52K | Form 4 |
| Jul 9, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 25 | $400 | Form 4 |
| Jul 9, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 25 | $25.25 | Form 4 |
| Jul 8, 2026 | Stengone Carmine N.CEO and President | Sale | 2,500 | $40.00K | Form 4 |
| Jul 8, 2026 | Stengone Carmine N.CEO and President | Option exercise | 2,500 | $2.52K | Form 4 |
| Jul 8, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 1,015 | $16.24K | Form 4 |
| Jul 8, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 1,015 | $1.03K | Form 4 |
| Jul 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 2,501 | $40.61K | Form 4 |
| Jul 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 5,852 | $91.68K | Form 4 |
| Jul 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 4,183 | $4.22K | Form 4 |
| Jun 30, 2026 | Stengone Carmine N.CEO and President | Sale | 10,000 | $160.08K | Form 4 |
| Jun 30, 2026 | Stengone Carmine N.CEO and President | Option exercise | 2,500 | $3.15K | Form 4 |
| Jun 30, 2026 | Stengone Carmine N.CEO and President | Option exercise | 7,500 | $7.58K | Form 4 |
| Jun 30, 2026 | Watkins TimCMO & Head of Development | Sale | 10,833 | $173.59K | Form 4 |
| Jun 30, 2026 | Watkins TimCMO & Head of Development | Option exercise | 10,833 | $48.75K | Form 4 |
| Jun 30, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 28,826 | $462.29K | Form 4 |
| Jun 30, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 28,826 | $29.11K | Form 4 |
| Jun 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 4,170 | $54.86K | Form 4 |
| May 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 300 | $4.15K | Form 4 |
| May 1, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 3,870 | $50.54K | Form 4 |
| Apr 6, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 4,170 | $56.01K | Form 4 |
| Mar 2, 2026 | Watkins TimCMO & Head of Development | Sale | 3,611 | $54.22K | Form 4 |
| Mar 2, 2026 | Watkins TimCMO & Head of Development | Option exercise | 3,611 | $16.25K | Form 4 |
| Mar 2, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 4,170 | $62.59K | Form 4 |
| Feb 25, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 3,824 | $61.23K | Form 4 |
| Feb 25, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 3,824 | $3.86K | Form 4 |
| Feb 25, 2026 | Stengone Carmine N.CEO and President | Sale | 2,700 | $43.24K | Form 4 |
| Feb 25, 2026 | Stengone Carmine N.CEO and President | Option exercise | 2,700 | $3.40K | Form 4 |
| Feb 24, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 4,300 | $68.94K | Form 4 |
| Feb 24, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 4,300 | $4.34K | Form 4 |
| Feb 24, 2026 | Stengone Carmine N.CEO and President | Sale | 4,400 | $70.49K | Form 4 |
| Feb 24, 2026 | Stengone Carmine N.CEO and President | Option exercise | 4,400 | $5.54K | Form 4 |
| Feb 19, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 100 | $1.60K | Form 4 |
| Feb 19, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 100 | $101 | Form 4 |
| Feb 11, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 400 | $6.40K | Form 4 |
| Feb 11, 2026 | Lorrain Daniel S.Chief Scientific Officer | Option exercise | 400 | $404 | Form 4 |
| Feb 11, 2026 | Stengone Carmine N.CEO and President | Sale | 400 | $6.40K | Form 4 |
| Feb 11, 2026 | Stengone Carmine N.CEO and President | Option exercise | 400 | $504 | Form 4 |
| Feb 3, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 1,170 | $17.84K | Form 4 |
| Feb 3, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 3,000 | $44.47K | Form 4 |
| Jan 28, 2026 | Watkins TimCMO & Head of Development | Sale | 811 | $11.75K | Form 4 |
| Jan 28, 2026 | Watkins TimCMO & Head of Development | Sale | 2,800 | $39.44K | Form 4 |
| Jan 28, 2026 | Watkins TimCMO & Head of Development | Option exercise | 3,611 | $16.25K | Form 4 |
| Jan 5, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 500 | $5.56K | Form 4 |
| Jan 5, 2026 | Lorrain Daniel S.Chief Scientific Officer | Sale | 3,670 | $37.98K | Form 4 |
| Dec 29, 2025 | Watkins TimCMO & Head of Development | Sale | 3,611 | $43.56K | Form 4 |
| Dec 29, 2025 | Watkins TimCMO & Head of Development | Option exercise | 3,611 | $16.25K | Form 4 |
| Dec 23, 2025 | Lorrain Daniel S.Chief Scientific Officer | Sale | 4,170 | $51.01K | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4